BLA accepted, priority review granted by US FDA for Viridian Viridian Therapeutics’ veligrotug | Optometry Times - Clinical News

Published on December 22, 2025
The PDUFA target action date is June 30, 2026.
Continue reading on website
Other news

The Body Doctor co-founders to take on London Marathon

December 22, 2025
Sam and Adam Wymer will run the 2026 London Marathon to raise funds for Pancreatic Cancer UK, in memory of their father

American Optometric Association

December 23, 2025
An estimated 12 million Americans ages 40+ are living with uncorrectable vision loss: https://ow.ly/FRvX50XNIzvDoctors of optometry across the U.S. can provide support that can help. Find an AOA...